These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

482 related items for PubMed ID: 19156903

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Long-term clinical outcome after postchemotherapy retroperitoneal lymph node dissection in men with residual teratoma.
    Carver BS, Shayegan B, Serio A, Motzer RJ, Bosl GJ, Sheinfeld J.
    J Clin Oncol; 2007 Mar 20; 25(9):1033-7. PubMed ID: 17261854
    [Abstract] [Full Text] [Related]

  • 3. Viable germ cell tumor at postchemotherapy retroperitoneal lymph node dissection: can we predict patients at risk of disease progression?
    Spiess PE, Tannir NM, Tu SM, Brown GA, Liu P, Kamat AM, Wood CG, Evans JG, Pisters LL.
    Cancer; 2007 Dec 15; 110(12):2700-8. PubMed ID: 17948916
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Incidence of metastatic nonseminomatous germ cell tumor outside the boundaries of a modified postchemotherapy retroperitoneal lymph node dissection.
    Carver BS, Shayegan B, Eggener S, Stasi J, Motzer RJ, Bosl GJ, Sheinfeld J.
    J Clin Oncol; 2007 Oct 01; 25(28):4365-9. PubMed ID: 17906201
    [Abstract] [Full Text] [Related]

  • 9. Results of retroperitoneal lymph node dissection after chemotherapy in patients with pure seminoma in the orchidectomy specimen but elevated serum alpha-fetoprotein.
    Peterson M, Beck S, Bihrle R, Einhorn L, Foster R.
    BJU Int; 2009 Jul 01; 104(2):176-8. PubMed ID: 19493258
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Primary vs. post-chemotherapy retroperitoneal lymph node dissection (RPLND) in patients with presence of teratoma at orchiectomy.
    Williams SB, Kacker R, Steele GS, Richie JP.
    Urol Oncol; 2012 Jul 01; 30(1):60-3. PubMed ID: 20189842
    [Abstract] [Full Text] [Related]

  • 14. Clinical outcome following post-chemotherapy retroperitoneal lymph node dissection in men with intermediate- and poor-risk nonseminomatous germ cell tumour.
    Shayegan B, Carver BS, Stasi J, Motzer RJ, Bosl GJ, Sheinfeld J.
    BJU Int; 2007 May 01; 99(5):993-7. PubMed ID: 17437432
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Repeat retroperitoneal lymph-node dissection after chemotherapy for metastatic testicular germ cell tumour.
    Willis SF, Winkler M, Savage P, Seckl MJ, Christmas TJ.
    BJU Int; 2007 Oct 01; 100(4):809-12. PubMed ID: 17711512
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Is full bilateral retroperitoneal lymph node dissection always necessary for postchemotherapy residual tumor?
    Beck SD, Foster RS, Bihrle R, Donohue JP, Einhorn LH.
    Cancer; 2007 Sep 15; 110(6):1235-40. PubMed ID: 17665498
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Long-term results of laparoscopic retroperitoneal lymph node dissection: a single-center 10-year experience.
    Steiner H, Peschel R, Janetschek G, Höltl L, Berger AP, Bartsch G, Hobisch A.
    Urology; 2004 Mar 15; 63(3):550-5. PubMed ID: 15028456
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.